Rising R&D Investments and Demand for Bioavailability-Enhancing Solutions Fuel Market Expansion
Dublin, May 16, 2025 (GLOBE NEWSWIRE) -- The "Formulation Development Outsourcing Market Size, Share & Trends Analysis Report by Service (Preformulation, Formulation Development), Formulation, Therapeutic Area, End-use, Region, with Growth Forecasts, 2025-2030" report has been added to ResearchAndMarkets.com's offering.
The Formulation Development Outsourcing Market was valued at USD 37.27 Billion in 2024, and is projected to reach USD 60.66 Billion by 2030, rising at a CAGR of 8.62%.
The high burden of chronic and infectious diseases, the growing focus on improving the bioavailability of poorly soluble drugs, and the complications associated with drug development are contributing to the demand for formulation development services globally. Furthermore, the COVID-19 outbreak has influenced the need for clinical trials to find an effective treatment against the contagious virus. This has resulted in significant investments in research and development (R&D) to develop therapeutics, which are expected to drive the market.
Formulation Development Outsourcing Market Insights
Why Should You Buy This Report?
This report addresses:
Key Attributes
Report Attribute | Details |
No. of Pages | 120 |
Forecast Period | 2024-2030 |
Estimated Market Value (USD) in 2024 | $37.27 Billion |
Forecasted Market Value (USD) by 2030 | $60.66 Billion |
Compound Annual Growth Rate | 8.6% |
Regions Covered | Global |
Key Topics Covered
Chapter 1. Research Methodology and Scope
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Formulation Development Outsourcing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Clinical Trials Volume Analysis, (2024)
3.3.1. Total Number of Clinical Trials by Region
3.3.2. Total Number of Clinical Trials, by Phase
3.3.3. Total Number of Clinical Trials, by Study Design
3.3.4. Total Number of Clinical Trials, by Key Therapeutic Area
3.4. Pricing Model Analysis
3.5. Technology Landscape
3.6. Market Analysis Tools
3.6.1. Porter's Five Force Analysis
3.6.2. PESTEL by SWOT Analysis
3.6.3. COVID-19 Impact Analysis
Chapter 4. Formulation Development Outsourcing Market: Service Estimates & Trend Analysis
4.1. Formulation Development Outsourcing Market, by Service: Segment Dashboard
4.2. Formulation Development Outsourcing Market, by Service: Movement Analysis
4.3. Formulation Development Outsourcing Market Estimates & Forecasts, by Service, 2018-2030
4.4. Preformulation
4.5. Formulation Development
Chapter 5. Formulation Development Outsourcing Market: Formulation Estimates & Trend Analysis
5.1. Formulation Development Outsourcing Market, by Formulation: Segment Dashboard
5.2. Formulation Development Outsourcing Market, by Formulation: Movement Analysis
5.3. Formulation Development Outsourcing Market Estimates & Forecasts, by Formulation, 2018-2030
5.4. Oral
5.5. Injectable
5.6. Topical
5.7. Others
Chapter 6. Formulation Development Outsourcing Market: Therapeutic Area Estimates & Trend Analysis
6.1. Formulation Development Outsourcing Market, by Therapeutic Area: Segment Dashboard
6.2. Formulation Development Outsourcing Market, by Therapeutic Area: Movement Analysis
6.3. Formulation Development Outsourcing Market Estimates & Forecasts, by Therapeutic Area, 2018-2030
6.4. Oncology
6.5. Infectious Disease
6.6. Neurology
6.7. Hematology
6.8. Respiratory
6.9. Cardiovascular
6.10. Dermatology
6.11. Others
Chapter 7. Formulation Development Outsourcing Market: End Use Estimates & Trend Analysis
7.1. Formulation Development Outsourcing Market, by End Use: Segment Dashboard
7.2. Formulation Development Outsourcing Market, by End Use: Movement Analysis
7.3. Formulation Development Outsourcing Market Estimates & Forecasts, by End Use, 2018-2030
7.4. Pharmaceutical and Biopharmaceutical Companies
7.5. Government and Academic Institutes
7.6. Others
Chapter 8. Formulation Development Outsourcing Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2024 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. North America
8.5. Europe
8.6. Asia-Pacific
8.7. Latin America
8.8. MEA
Chapter 9. Competitive Landscape
9.1. Market Participant Categorization
9.2. Company Market Share/Assessment Analysis, 2024
9.3. Company Profiles
9.3.1. SGS Limited SA
9.3.2. Intertek Group plc
9.3.3. Recipharm
9.3.4. Lonza
9.3.5. Charles River Laboratories International, Inc.
9.3.6. Eurofins Scientific SE
9.3.7. Element
9.3.8. Labcorp
9.3.9. Thermo Fisher Scientific , Inc.
9.3.10. Catalent Inc.
Chapter 10. Key Recommendations
For more information about this report visit https://www.researchandmarkets.com/r/6pjxkw
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900